Showing 4,821 - 4,840 results of 9,440 for search 'significantly ((we decrease) OR (((mean decrease) OR (greater decrease))))', query time: 0.49s Refine Results
  1. 4821

    Data Sheet 1_Secreted PD-L1 alleviates inflammatory arthritis in mice through local and systemic AAV gene therapy.pdf by Wenjun Li (41954)

    Published 2025
    “…The levels of pro-inflammatory cytokines in blood were also significantly decreased in shPD-L1 treated mice. Additionally, T cell apoptosis rates in the spleen showed a 2-fold increase in treated mice. …”
  2. 4822
  3. 4823

    Table 1_Inhibitory control in the sober state as a function of alcohol sensitivity: a pilot functional magnetic resonance imaging (fMRI) study.docx by Roberto U. Cofresí (20800094)

    Published 2025
    “…Within group HS, IC-related dACC activity was greater among individuals reporting less intense (b-95 CI = [−0.201, −0.041], p = 0.004) and less frequent alcohol craving experiences (b-95 CI = [−0.131, 0.005], p = 0.068), whereas in group LS, IC-related dACC activity was greater among individuals reporting more intense (b-95 CI = [0.009, 0.140], p = 0.028) and more frequent alcohol craving experiences (b-95 CI = [0.022, 0.128], p = 0.007).…”
  4. 4824

    Table 2_Inhibitory control in the sober state as a function of alcohol sensitivity: a pilot functional magnetic resonance imaging (fMRI) study.docx by Roberto U. Cofresí (20800094)

    Published 2025
    “…Within group HS, IC-related dACC activity was greater among individuals reporting less intense (b-95 CI = [−0.201, −0.041], p = 0.004) and less frequent alcohol craving experiences (b-95 CI = [−0.131, 0.005], p = 0.068), whereas in group LS, IC-related dACC activity was greater among individuals reporting more intense (b-95 CI = [0.009, 0.140], p = 0.028) and more frequent alcohol craving experiences (b-95 CI = [0.022, 0.128], p = 0.007).…”
  5. 4825

    Table 1_Impact of co-infections and immune responses on clinical severity of human adenovirus 3 and 7 infections in hospitalized children with lower respiratory tract infections: a... by Xiaolin Ma (701778)

    Published 2025
    “…</p>Conclusions<p>Hospitalized children with HAdV-7-associated LRTIs exhibit greater severity, multiple infections, and significant potential for greater cellular immune dysregulation compared to those with HAdV-3 infection, indicating a more severe clinical course and distinct pathogenic profiles.…”
  6. 4826

    Data Sheet 1_Integrative metabolomics and proteomics reveal the effects and mechanisms of Salvia miltiorrhiza in alleviating traumatic blood stasis syndrome.docx by Pei Guo (1574110)

    Published 2025
    “…Additionally, there was a significant decrease in APTT, PT, TT, t-PA, IL-10, 6-Keto-PGF1α, and FN. …”
  7. 4827

    Neutrophil recruitment after <i>H</i>. <i>pylori</i> infection monitored by multiphoton microscopy <i>in vivo</i>. by Hellen Ishikawa-Ankerhold (5900822)

    Published 2024
    “…<i>pylori</i> infection and decrease after 6 weeks of infection. n = 4 mice. ****p<0.0001, ***p<0.001, **p<0.01, *p<0.05, or not significant (ns). …”
  8. 4828

    Table 3_Effects of extracorporeal carbon dioxide removal in facilitating ultra-protective ventilation strategies for patients with acute respiratory distress syndrome: a systematic... by Weifeng Zhen (12969341)

    Published 2025
    “…ECCO<sub>2</sub>R significantly reduced driving pressure (weighted mean difference [WMD]: −3.70 cmH<sub>2</sub>O; 95% CI: −4.05 to −3.34; P < 0.001), plateau pressure (WMD: −3.26 cmH<sub>2</sub>O; 95% CI: −3.70 to −2.82; P < 0.001), and tidal volume (WMD: −1.68 mL/kg; 95% CI: −1.81 to −1.55; P < 0.001) at 24 h, while it increased positive end-expiratory pressure (WMD: 0.64 cmH<sub>2</sub>O; 95% CI: 0.44 to 0.85; P < 0.001). …”
  9. 4829

    Table 1_Effects of extracorporeal carbon dioxide removal in facilitating ultra-protective ventilation strategies for patients with acute respiratory distress syndrome: a systematic... by Weifeng Zhen (12969341)

    Published 2025
    “…ECCO<sub>2</sub>R significantly reduced driving pressure (weighted mean difference [WMD]: −3.70 cmH<sub>2</sub>O; 95% CI: −4.05 to −3.34; P < 0.001), plateau pressure (WMD: −3.26 cmH<sub>2</sub>O; 95% CI: −3.70 to −2.82; P < 0.001), and tidal volume (WMD: −1.68 mL/kg; 95% CI: −1.81 to −1.55; P < 0.001) at 24 h, while it increased positive end-expiratory pressure (WMD: 0.64 cmH<sub>2</sub>O; 95% CI: 0.44 to 0.85; P < 0.001). …”
  10. 4830

    Table 2_Effects of extracorporeal carbon dioxide removal in facilitating ultra-protective ventilation strategies for patients with acute respiratory distress syndrome: a systematic... by Weifeng Zhen (12969341)

    Published 2025
    “…ECCO<sub>2</sub>R significantly reduced driving pressure (weighted mean difference [WMD]: −3.70 cmH<sub>2</sub>O; 95% CI: −4.05 to −3.34; P < 0.001), plateau pressure (WMD: −3.26 cmH<sub>2</sub>O; 95% CI: −3.70 to −2.82; P < 0.001), and tidal volume (WMD: −1.68 mL/kg; 95% CI: −1.81 to −1.55; P < 0.001) at 24 h, while it increased positive end-expiratory pressure (WMD: 0.64 cmH<sub>2</sub>O; 95% CI: 0.44 to 0.85; P < 0.001). …”
  11. 4831

    Table 4_Effects of extracorporeal carbon dioxide removal in facilitating ultra-protective ventilation strategies for patients with acute respiratory distress syndrome: a systematic... by Weifeng Zhen (12969341)

    Published 2025
    “…ECCO<sub>2</sub>R significantly reduced driving pressure (weighted mean difference [WMD]: −3.70 cmH<sub>2</sub>O; 95% CI: −4.05 to −3.34; P < 0.001), plateau pressure (WMD: −3.26 cmH<sub>2</sub>O; 95% CI: −3.70 to −2.82; P < 0.001), and tidal volume (WMD: −1.68 mL/kg; 95% CI: −1.81 to −1.55; P < 0.001) at 24 h, while it increased positive end-expiratory pressure (WMD: 0.64 cmH<sub>2</sub>O; 95% CI: 0.44 to 0.85; P < 0.001). …”
  12. 4832

    Table 5_Effects of extracorporeal carbon dioxide removal in facilitating ultra-protective ventilation strategies for patients with acute respiratory distress syndrome: a systematic... by Weifeng Zhen (12969341)

    Published 2025
    “…ECCO<sub>2</sub>R significantly reduced driving pressure (weighted mean difference [WMD]: −3.70 cmH<sub>2</sub>O; 95% CI: −4.05 to −3.34; P < 0.001), plateau pressure (WMD: −3.26 cmH<sub>2</sub>O; 95% CI: −3.70 to −2.82; P < 0.001), and tidal volume (WMD: −1.68 mL/kg; 95% CI: −1.81 to −1.55; P < 0.001) at 24 h, while it increased positive end-expiratory pressure (WMD: 0.64 cmH<sub>2</sub>O; 95% CI: 0.44 to 0.85; P < 0.001). …”
  13. 4833

    Supplementary Material for: Long-term trends in incidence, attack rates, and early case-fatality of spontaneous intracerebral hemorrhage. Dijon Stroke Registry (1985-2022) by figshare admin karger (2628495)

    Published 2025
    “…Results: 1,015 ICH cases (mean age 73.5 ±16.4 years old, 52.7% women) were recorded including 815 patients with a first-ever ICH and 200 cases of ICH as stroke recurrences. …”
  14. 4834

    Image 2_Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic.tif by Fengge Wang (4347442)

    Published 2025
    “…</p>Results<p>After the 25-day intervention, the GDM model + AS IV group showed significantly decreased fasting blood glucose levels (p = 0.0003), mean insulin levels (p = 0.0001), and insulin resistance index (p = 0.0001). …”
  15. 4835

    Image 1_Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic.tif by Fengge Wang (4347442)

    Published 2025
    “…</p>Results<p>After the 25-day intervention, the GDM model + AS IV group showed significantly decreased fasting blood glucose levels (p = 0.0003), mean insulin levels (p = 0.0001), and insulin resistance index (p = 0.0001). …”
  16. 4836

    Table 1_Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic.xlsx by Fengge Wang (4347442)

    Published 2025
    “…</p>Results<p>After the 25-day intervention, the GDM model + AS IV group showed significantly decreased fasting blood glucose levels (p = 0.0003), mean insulin levels (p = 0.0001), and insulin resistance index (p = 0.0001). …”
  17. 4837

    Table 2_Astragaloside IV alleviates GDM via regulating gut microbiota and gut microbiota metabolomic.xlsx by Fengge Wang (4347442)

    Published 2025
    “…</p>Results<p>After the 25-day intervention, the GDM model + AS IV group showed significantly decreased fasting blood glucose levels (p = 0.0003), mean insulin levels (p = 0.0001), and insulin resistance index (p = 0.0001). …”
  18. 4838

    Datasheet1_Efficacy and safety of Danlou tablets in the treatment of stable angina pectoris with intermingled phlegm and blood stasis syndrome in coronary heart disease: a multicen... by Zeng Li (688702)

    Published 2024
    “…The activated partial thromboplastin time in the treatment group decreased significantly (P < 0.05). There was no statistically significant difference in the safety indicators and incidence of adverse reactions between the two groups.…”
  19. 4839

    Datasheet2_Efficacy and safety of Danlou tablets in the treatment of stable angina pectoris with intermingled phlegm and blood stasis syndrome in coronary heart disease: a multicen... by Zeng Li (688702)

    Published 2024
    “…The activated partial thromboplastin time in the treatment group decreased significantly (P < 0.05). There was no statistically significant difference in the safety indicators and incidence of adverse reactions between the two groups.…”
  20. 4840

    Datasheet1_Efficacy and safety of Danlou tablets in the treatment of stable angina pectoris with intermingled phlegm and blood stasis syndrome in coronary heart disease: a multicen... by Zeng Li (688702)

    Published 2024
    “…The activated partial thromboplastin time in the treatment group decreased significantly (P < 0.05). There was no statistically significant difference in the safety indicators and incidence of adverse reactions between the two groups.…”